GLENVIEW CAPITAL MANAGEMENT, LLC: GENI position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GLENVIEW CAPITAL MANAGEMENT, LLC on GENI, newest first. How the timeline and the estimate are built.
GLENVIEW CAPITAL MANAGEMENT, LLC held 16,620,590 GENI shares at 2026-09-30 per its 13F-HR filed 2026-11-16.
no 13D/G or Form 3/4/5 step is dated after the latest 13F period 2026-09-30
- event date2026-09-3013G/A 16,620,590 sharesShare basis changed not comparable
6.2% of the class. Different basis (group aggregate from 13G/A).
13G/A 0000905148-26-004932 filed by GLENVIEW CAPITAL MANAGEMENT, LLC
Accepted , ingestedA 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.
- period ended2026-09-3013F 16,620,590 sharesChange vs previous 13F +3,125,303 shares
1.69% of the 13F portfolio, value $95,235,981.
13F-HR 0000905148-26-004892 filed by GLENVIEW CAPITAL MANAGEMENT, LLC
Accepted , ingested - period ended2026-06-3013F 13,495,287 sharesChange vs previous 13F +4,934,399 shares
1.63% of the 13F portfolio, value $81,781,439.
13F-HR 0000905148-26-003712 filed by GLENVIEW CAPITAL MANAGEMENT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 8,560,888 sharesChange vs previous 13F +6,530,679 shares
1.03% of the 13F portfolio, value $37,924,734.
13F-HR 0000905148-26-002354 filed by GLENVIEW CAPITAL MANAGEMENT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,030,209 sharesChange vs previous 13F not available
0.48% of the 13F portfolio, value $22,372,903.
13F-HR 0000905148-26-000846 filed by GLENVIEW CAPITAL MANAGEMENT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).